Kiran Dhillon
Seattle Met Magazine features CVI HER2 ICD DNA vaccine for breast cancer
Seattle Met Magazine recently interviewed CVI Director, Dr. Nora Disis, and CVI Director of Clinical Trials, Dr. Shaveta Vinayak on our...
top of page
Cancer Vaccine Institute Blog
Kiran Dhillon
- Nov 21, 2022
HER2 ICD vaccine trial findings featured on KIRO7 news
CVI's Executive Director Dr. Kiran Dhillon spoke with KIRO7 news anchors Monique Ming Laven and Gary Horcher about our recent publication...
Kiran Dhillon
- Nov 21, 2022
Breast Cancer Research Foundation funds CVI research on adipose-directed vaccine
We're grateful to the Breast Cancer Research Foundation for supporting our work in developing a vaccine that targets inflammation from...
Kiran Dhillon
- Nov 21, 2022
HER2 ICD DNA vaccine study featured on Good Morning America & ABC News
We're excited to see the findings from our recent publication in JAMA Oncology describing our Phase I clinical trial with the HER2 ICD...
Kiran Dhillon
- Oct 17, 2022
Dr. Disis shares the promise of cancer vaccines in interview with KUOW NPR
Check out CVI's Dr. Nora Disis' interview with KUOW NPR on the exciting prospects of cancer vaccines for therapy, cancer interception and...
Blog: Blog2
bottom of page